Exact Mass: 316.1051
Exact Mass Matches: 316.1051
Found 91 metabolites which its exact mass value is equals to given mass value 316.1051,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(3R,4S,6S,10R)-10-bromo-3,11,11-trimethyl-7-methylidenespiro[5.5]undecane-3,4-diol
(3R,4S,6S,10R)-10-bromo-3,11,11-trimethyl-7-methylidenespiro[5.5]undecane-3,4-diol
4-Hydroxy-gammar-snyderol|8-Hydroxy-gamma-snyderol
4-Hydroxy-gammar-snyderol|8-Hydroxy-gamma-snyderol
5,6-Dimethoxy-7-phenyl-phenalenon|5,6-Dimethoxy-7-phenylalenon|Lachnanthocarpondimethylether
5,6-Dimethoxy-7-phenyl-phenalenon|5,6-Dimethoxy-7-phenylalenon|Lachnanthocarpondimethylether
4,4-dihydroxy-2-methyl-3-[(4-hydroxyphenyl)ethynyl]biphene|selaginellin L
4,4-dihydroxy-2-methyl-3-[(4-hydroxyphenyl)ethynyl]biphene|selaginellin L
(1R*,5R*,6R*,8S*,9S*)-8-bromo-1,6-epoxy-5-isopropyl-3,3,9-trimethylbicyclo[4.3.0]nonan-9-ol
(1R*,5R*,6R*,8S*,9S*)-8-bromo-1,6-epoxy-5-isopropyl-3,3,9-trimethylbicyclo[4.3.0]nonan-9-ol
1-(1,2-difluoro-2-naphthalen-1-ylethenyl)naphthalene
1-(1,2-difluoro-2-naphthalen-1-ylethenyl)naphthalene
methyl (E)-3-methoxy-2-[2-(6-methoxypyrimidin-4-yl)oxyphenyl]prop-2-enoate
methyl (E)-3-methoxy-2-[2-(6-methoxypyrimidin-4-yl)oxyphenyl]prop-2-enoate
1-(4-fluorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
1-(4-fluorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
(4-Furan-2-yl-[4,5]bipyrimidinyl-2-yl)-pyridin-3-yl-amine
(4-Furan-2-yl-[4,5]bipyrimidinyl-2-yl)-pyridin-3-yl-amine
tert-butyl 4-[5-(chloromethyl)thiazol-2-yl]piperidine-1-carboxyla te
tert-butyl 4-[5-(chloromethyl)thiazol-2-yl]piperidine-1-carboxyla te
Methyl 2-(4’-Acetoxy-2-fluoro-biphenyl-4-yl)-propionate
Methyl 2-(4’-Acetoxy-2-fluoro-biphenyl-4-yl)-propionate
1-hexyl-3-methylimidazolium trifluoromethanesulfonate
1-hexyl-3-methylimidazolium trifluoromethanesulfonate
4-Chloro-6-methoxy-7-(4-methyl-1-piperazinyl)-3-quinolinecarbonit rile
4-Chloro-6-methoxy-7-(4-methyl-1-piperazinyl)-3-quinolinecarbonit rile
JNJ 63533054
JNJ 63533054
JNJ-63533054 is a potent, selective and orally active GPR139 agonist with an EC50 of 16 nM for human GPR139 (hGPR139). JNJ-63533054 shows selective for GPR139 over other GPCRs, ion channels, and transporters. JNJ-63533054 can cross the blood-brain barrier (BBB)[1][2].
N-Isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid
N-Isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid
2-[[Anilino(oxo)methyl]amino]-4,5-dimethoxybenzoic acid
2-[[Anilino(oxo)methyl]amino]-4,5-dimethoxybenzoic acid
1-(2-Chlorophenoxy)-3-(2-methyl-1-benzimidazolyl)-2-propanol
1-(2-Chlorophenoxy)-3-(2-methyl-1-benzimidazolyl)-2-propanol
Trisilane, 1,1,1,3,3,3-hexamethyl-2-(trifluoromethyl)-2-(trimethylsilyl)-
Trisilane, 1,1,1,3,3,3-hexamethyl-2-(trifluoromethyl)-2-(trimethylsilyl)-
9-(Chloromethyl)-9-hydroxy-1-oxo-6-propan-2-yl-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid
9-(Chloromethyl)-9-hydroxy-1-oxo-6-propan-2-yl-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid
1-Deoxy-1-({2,6-Dioxo-5-[(E)-(2-Oxoethylidene)amino]-1,2,3,6-Tetrahydropyrimidin-4-Yl}amino)-D-Ribitol
1-Deoxy-1-({2,6-Dioxo-5-[(E)-(2-Oxoethylidene)amino]-1,2,3,6-Tetrahydropyrimidin-4-Yl}amino)-D-Ribitol
1-(4-Acetylphenyl)-3-[2-(4-fluorophenyl)ethyl]thiourea
1-(4-Acetylphenyl)-3-[2-(4-fluorophenyl)ethyl]thiourea
N-(3-fluorophenyl)-2-pyridin-4-yl-4-quinazolinamine
N-(3-fluorophenyl)-2-pyridin-4-yl-4-quinazolinamine
3-Oxo-2-[(6-oxo-1-phenyl-3-pyridazinyl)oxy]butanoic acid ethyl ester
3-Oxo-2-[(6-oxo-1-phenyl-3-pyridazinyl)oxy]butanoic acid ethyl ester
1-[2-[(2-Methylphenyl)methylthio]ethyl]-3-phenylthiourea
1-[2-[(2-Methylphenyl)methylthio]ethyl]-3-phenylthiourea
5-hydroxy-3-(4-methylphenyl)-5-(trifluoromethyl)-4H-pyrazole-1-carboxylic acid ethyl ester
5-hydroxy-3-(4-methylphenyl)-5-(trifluoromethyl)-4H-pyrazole-1-carboxylic acid ethyl ester
2-Furanyl-[3-hydroxy-3-(trifluoromethyl)-3a,4,5,6,7,8-hexahydrocyclohepta[c]pyrazol-2-yl]methanone
2-Furanyl-[3-hydroxy-3-(trifluoromethyl)-3a,4,5,6,7,8-hexahydrocyclohepta[c]pyrazol-2-yl]methanone
H4 Receptor antagonist 1
H4 Receptor antagonist 1
H4 Receptor antagonist 1 is a potent and selective histamine H4 receptor inverse agonist, with an IC50 of 19 nM.
5-[5-(buta-1,3-dien-1-yl)thiophen-2-yl]pent-2-en-4-yn-1-yl 3-hydroxy-3-methylbutanoate
5-[5-(buta-1,3-dien-1-yl)thiophen-2-yl]pent-2-en-4-yn-1-yl 3-hydroxy-3-methylbutanoate
5-bromo-3-(3-hydroxy-3-methylpent-4-en-1-yl)-2,4,4-trimethylcyclohex-2-en-1-ol
5-bromo-3-(3-hydroxy-3-methylpent-4-en-1-yl)-2,4,4-trimethylcyclohex-2-en-1-ol
(3r,4r,7s,7as)-7-bromo-3-(1-hydroxy-2-methylprop-2-en-1-yl)-4,7a-dimethyl-hexahydro-1h-inden-4-ol
(3r,4r,7s,7as)-7-bromo-3-(1-hydroxy-2-methylprop-2-en-1-yl)-4,7a-dimethyl-hexahydro-1h-inden-4-ol
(3r)-6-[(1e)-4-(thiophen-2-yl)but-1-en-3-yn-1-yl]oxan-3-yl 3-methylbut-2-enoate
(3r)-6-[(1e)-4-(thiophen-2-yl)but-1-en-3-yn-1-yl]oxan-3-yl 3-methylbut-2-enoate
7-bromo-3-(1-hydroxy-2-methylprop-2-en-1-yl)-4,7a-dimethyl-hexahydro-1h-inden-4-ol
7-bromo-3-(1-hydroxy-2-methylprop-2-en-1-yl)-4,7a-dimethyl-hexahydro-1h-inden-4-ol
18-hydroxy-8-imino-3,10,20-triazapentacyclo[11.7.1.0²,⁷.0⁹,²¹.0¹⁴,¹⁹]henicosa-1(20),2(7),9,11,13(21),14(19),15,17-octaen-6-one
18-hydroxy-8-imino-3,10,20-triazapentacyclo[11.7.1.0²,⁷.0⁹,²¹.0¹⁴,¹⁹]henicosa-1(20),2(7),9,11,13(21),14(19),15,17-octaen-6-one
(1r,3s,5r)-5-bromo-3-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-4,4-dimethyl-2-methylidenecyclohexan-1-ol
(1r,3s,5r)-5-bromo-3-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-4,4-dimethyl-2-methylidenecyclohexan-1-ol
3-[2-(4-hydroxyphenyl)ethynyl]-2-methyl-[1,1'-biphenyl]-4,4'-diol
3-[2-(4-hydroxyphenyl)ethynyl]-2-methyl-[1,1'-biphenyl]-4,4'-diol
8-bromo-3,7,7-trimethyl-11-methylidenespiro[5.5]undecane-2,3-diol
8-bromo-3,7,7-trimethyl-11-methylidenespiro[5.5]undecane-2,3-diol
(5as,6r,9s,9as)-9-(chloromethyl)-9-hydroxy-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid
(5as,6r,9s,9as)-9-(chloromethyl)-9-hydroxy-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid
6-hydroxy-20-imino-2,12,15-triazapentacyclo[11.7.1.0³,⁸.0⁹,²¹.0¹⁴,¹⁹]henicosa-1,3(8),4,6,9(21),10,12,14(19)-octaen-18-one
6-hydroxy-20-imino-2,12,15-triazapentacyclo[11.7.1.0³,⁸.0⁹,²¹.0¹⁴,¹⁹]henicosa-1,3(8),4,6,9(21),10,12,14(19)-octaen-18-one
(2s)-6-[(1s)-1-hydroxyethyl]-3-({2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2s)-6-[(1s)-1-hydroxyethyl]-3-({2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2e)-5-{5-[(1e)-buta-1,3-dien-1-yl]thiophen-2-yl}pent-2-en-4-yn-1-yl 3-hydroxy-3-methylbutanoate
(2e)-5-{5-[(1e)-buta-1,3-dien-1-yl]thiophen-2-yl}pent-2-en-4-yn-1-yl 3-hydroxy-3-methylbutanoate
(1r,2r,6r,7s,8s)-8-bromo-2-isopropyl-4,4,7-trimethyl-10-oxatricyclo[4.3.1.0¹,⁶]decan-7-ol
(1r,2r,6r,7s,8s)-8-bromo-2-isopropyl-4,4,7-trimethyl-10-oxatricyclo[4.3.1.0¹,⁶]decan-7-ol
(3r,3as,4r,7s,7as)-7-bromo-3-[(1s)-1-hydroxy-2-methylprop-2-en-1-yl]-4,7a-dimethyl-hexahydro-1h-inden-4-ol
(3r,3as,4r,7s,7as)-7-bromo-3-[(1s)-1-hydroxy-2-methylprop-2-en-1-yl]-4,7a-dimethyl-hexahydro-1h-inden-4-ol
8-(1-carboxyethyl)-5-(chloromethyl)-5-hydroxy-4,4a,6,7,8,8a-hexahydro-3h-naphthalene-2-carboxylic acid
8-(1-carboxyethyl)-5-(chloromethyl)-5-hydroxy-4,4a,6,7,8,8a-hexahydro-3h-naphthalene-2-carboxylic acid
(3ar,4as,6s,7ar,8r,9as)-8-(chloromethyl)-4a,6,8-trihydroxy-3-methyl-5-methylidene-octahydroazuleno[6,5-b]furan-2-one
(3ar,4as,6s,7ar,8r,9as)-8-(chloromethyl)-4a,6,8-trihydroxy-3-methyl-5-methylidene-octahydroazuleno[6,5-b]furan-2-one
4-{2-methoxy-4-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]phenyl}-2-methyl-3-oxopyrazin-1-ium-1-olate
4-{2-methoxy-4-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]phenyl}-2-methyl-3-oxopyrazin-1-ium-1-olate
8-bromo-2-isopropyl-4,4,7-trimethyl-10-oxatricyclo[4.3.1.0¹,⁶]decan-7-ol
8-bromo-2-isopropyl-4,4,7-trimethyl-10-oxatricyclo[4.3.1.0¹,⁶]decan-7-ol
(4as,5r,8s,8as)-8-[(1r)-1-carboxyethyl]-5-(chloromethyl)-5-hydroxy-4,4a,6,7,8,8a-hexahydro-3h-naphthalene-2-carboxylic acid
(4as,5r,8s,8as)-8-[(1r)-1-carboxyethyl]-5-(chloromethyl)-5-hydroxy-4,4a,6,7,8,8a-hexahydro-3h-naphthalene-2-carboxylic acid
(1r,5r)-5-bromo-3-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-2,4,4-trimethylcyclohex-2-en-1-ol
(1r,5r)-5-bromo-3-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-2,4,4-trimethylcyclohex-2-en-1-ol
5-bromo-3-(3-hydroxy-3-methylpent-4-en-1-yl)-4,4-dimethyl-2-methylidenecyclohexan-1-ol
5-bromo-3-(3-hydroxy-3-methylpent-4-en-1-yl)-4,4-dimethyl-2-methylidenecyclohexan-1-ol
(3r,3as,4r,7s,7as)-7-bromo-3-[(1r)-1-hydroxy-2-methylprop-2-en-1-yl]-4,7a-dimethyl-hexahydro-1h-inden-4-ol
(3r,3as,4r,7s,7as)-7-bromo-3-[(1r)-1-hydroxy-2-methylprop-2-en-1-yl]-4,7a-dimethyl-hexahydro-1h-inden-4-ol
(2s,3r,6s,8r)-8-bromo-3,7,7-trimethyl-11-methylidenespiro[5.5]undecane-2,3-diol
(2s,3r,6s,8r)-8-bromo-3,7,7-trimethyl-11-methylidenespiro[5.5]undecane-2,3-diol
(2r,3r,5r)-5-bromo-2,6,6-trimethyl-2-[(1s)-4-methylcyclohex-3-en-1-yl]oxan-3-ol
(2r,3r,5r)-5-bromo-2,6,6-trimethyl-2-[(1s)-4-methylcyclohex-3-en-1-yl]oxan-3-ol
6-chloro-1-[2-(hydroxymethyl)-3-methoxyphenyl]hept-1-ene-3,4,5-triol
6-chloro-1-[2-(hydroxymethyl)-3-methoxyphenyl]hept-1-ene-3,4,5-triol
(1e,3r,4r,5r,6s)-6-chloro-1-[2-(hydroxymethyl)-3-methoxyphenyl]hept-1-ene-3,4,5-triol
(1e,3r,4r,5r,6s)-6-chloro-1-[2-(hydroxymethyl)-3-methoxyphenyl]hept-1-ene-3,4,5-triol
5-bromo-2,6,6-trimethyl-2-(4-methylcyclohex-3-en-1-yl)oxan-3-ol
5-bromo-2,6,6-trimethyl-2-(4-methylcyclohex-3-en-1-yl)oxan-3-ol
